The DOI matches its Crossref record; 86 of the 89 references it cites were found in a registry or an index.
Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4
Abstract
Since 2000, Escherichia coli producing CTX-M enzymes have emerged worldwide as important causes of community-onset urinary tract and bloodstream infections owing to extended-spectrum beta-lactamase (ESBL)-producing bacteria. Molecular epidemiological studies suggested that the sudden worldwide increase of CTX-M-15-producing E. coli was mainly due to a single clone (ST131) and that foreign travel to high-risk areas, such as the Indian subcontinent, might in part play a role in the spread of this clone across different continents. Empirical antibiotic coverage for these resistant organisms should be considered in community patients presenting with sepsis involving the urinary tract, especially if the patient recently travelled to a high-risk area. If this emerging public health threat is ignored, it is possible that the medical community may be forced, in the near future, to use carbapenems as the first choice for the empirical treatment of serious infections associated with urinary tract infections originating from the community.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The molecular epidemiology of the ESBL-E enzymes identified in the Madagascar (Chereau et al., 2015), Nigeria (Fortini et al., 2015), Cameroon (Djuikoue et al., 2016b), and Mozambique (Sáez-lópez et al., 2016) studies was in keeping with the global predominance of the CTX-M clone, which is also widely reported in community-acquired UTI (Pitout et al., 2005;Peirano and Pitout, 2010;Pallecchi et al.”
From Maternal colonization or infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in Africa: A systematic review and meta-analysis (2017) · cites this paper as Peirano and Pitout, 2010
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,203
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,068
Self-citationGrowing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Resistance Plasmid Families in Enterobacteriaceae
Carattoli, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-08 · Cited by 1,294
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,149
Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D. N., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,121
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A. A., Strahilevitz, J., Jacoby, G. A., Macielag, M. J., Abbanat, D., Park, C. H., Bush, K., & Hooper, D. C. (2005) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,011
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Cantón, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J. A., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon‐Guibout, V., Demarty, R., Alonso, M. P., Caniça, M., Park, Y. J., Lavigne, J., Pitout, J. D. D., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 815
Self-citation
Cited by
Sorted by citations
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 1,001
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González‐Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 993
Antimicrobial Resistance in Escherichia coli
Poirel, L., Madec, J.-Y., Lupo, A., Schink, A., Kieffer, N., Nordmann, P., & Schwarz, Š. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0026-2017 · Cited by 969
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 901
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akova, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 896
Metadata
- Authors
- Peirano, G., & Pitout, J. D. D.
- Affiliations
- University of Calgary (CA)
- ORCID
- Pitout, Johann D.D.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 35
- Issue
- 4
- Pages
- 316-321
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2087341525
- Cited by
- 443
- References
- 89
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 14 · 2021: 15 · 2020: 18 · 2019: 28 · 2018: 20 · 2017: 18 · 2016: 39 · 2015: 35 · 2014: 49 · 2013: 52 · 2012: 56
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Antimicrobial Agents (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Keywords
- Escherichia coli, CTX-M, ST131, extended-spectrum beta-lactamase, molecular epidemiology, antimicrobial resistance, urinary tract infection, bloodstream infection, sepsis, international travel, Indian subcontinent, empirical antibiotic therapy, carbapenems
- MeSH terms
- Anti-Bacterial Agents, beta-Lactamases, Disease Outbreaks, Escherichia coli, Escherichia coli Infections, Humans, Travel, Urinary Tract Infections, Bacterial Typing Techniques, Bacteremia, Molecular Epidemiology, Escherichia coli Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
